ROVI ACHIEVED OPERATING REVENUE OF 564.6 MILLION EUROS AND INCREASED ITS GROSS MARGIN BY 4.7 PERCENTAGE POINTS
4 min
07 Nov, 2024
ROVI ACHIEVED OPERATING REVENUE OF 329.3 MILLION EUROS AND INCREASED ITS GROSS MARGIN BY 2.8 PERCENTAGE POINTS
7 min
31 Jul, 2024
The Community of Madrid has declared this project to be strategic: it will create 200 new direct jobs for 2027 and...
4 min
11 Jul, 2024
ROVI reinforces its heparin production capacity
3 min
20 Jun, 2024
ROVI closes the quarter with operating revenue of 151.2 million euros
4 min
08 May, 2024
Agreement to manufacture pre-filled syringes for a global pharmaceutical company
3 min
25 Apr, 2024
Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the treatment of...
4 min
02 Apr, 2024